GlassScriptPhysician profile
Calvin J Hansen
NPI 1639157373
$1,234.16
in general payments reported to CMS, 2019-2025
10 companies · $70.61 in 2025
The $70.61 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $46.51 · 2021: $383 · 2022: $327 · 2023: $140 · 2024: $135 · 2025: $70.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278 · Education: $67.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.27 |
| Education | $67.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $600.49 | 2021-2025 | Vumerity, Tecfidera, Tysabri |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Abbvie INC. | $122.00 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $108.33 | 2019 | |
| Genentech USA, INC. | $89.51 | 2021-2025 | Ocrevus Zunovo |
| Novartis Pharmaceuticals Corporation | $88.76 | 2020-2025 | |
| Tg Therapeutics, INC. | $40.08 | 2024-2025 | |
| Braemar Manufacturing, LLC | $22.99 | 2019 | |
| Kyowa Kirin, INC. | $19.18 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $17.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.